ILOZOLE SB 130 CAPSULE

Product Description

ILOZOLE SB 130 CAPSULE is a high-strength systemic antifungal medication formulated with Itraconazole 130 mg, designed to effectively treat a wide range of fungal infections affecting the skin, nails, and internal organs. Known for its broad-spectrum antifungal action and enhanced absorption, this capsule is ideal for oral treatment of resistant fungal infections.

Manufactured in WHO-GMP certified facilities, ILOZOLE SB 130 ensures superior bioavailability, therapeutic efficacy, and patient compliance, making it a preferred choice among dermatologists, infectious disease specialists, and hospital pharmacies.

Key Benefits:

• Contains Itraconazole 130 mg for effective treatment of deep and systemic mycoses

• Broad-spectrum activity against dermatophytes, yeasts, and molds

• Improved pharmacokinetics for better clinical outcomes

• Reliable option for refractory and chronic fungal infections

Applications:

• Treatment of onychomycosis (nail fungus), tinea corporis, tinea pedis, and candidiasis

• Used in systemic fungal infections including aspergillosis and histoplasmosis

• Ideal for both acute and long-term antifungal therapy

Why Choose ILOZOLE SB 130 CAPSULE?

• High-demand formulation for specialized antifungal treatment

• Trusted by clinics, hospitals, and dermatology centers

• Excellent trade margins for wholesalers and PCD pharma distributors